FDA would collect millions to speed review of generic drugs
from The Associated Press via The Washington Post
The Food and Drug Administration would collect hundreds of millions of dollars in new fees from pharmaceutical companies to help speed up the review of generic drugs, under an agreement with industry released by the agency. The agreements would each charge drug manufacturers application fees for reviewing traditional drugs, generic drugs and a new class of generic biotech drugs, respectively.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063